Clinical studies recruiting near Kalamazoo

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed
Phase 3 · Bronson Methodist Hospital · National Cancer Institute (NCI) · NCT06172296 Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small C
Phase 3 · Bronson Methodist Hospital · NRG Oncology · NCT05624996 A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma
Phase 2/Phase 3 · Bronson Methodist Hospital · National Cancer Institute (NCI) · NCT05691478 A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT
Phase 2 · Bronson Methodist Hospital · Children's Oncology Group · NCT04322318 A Study of the Feasibility, Safety and Tolerability of Aticaprant as Adjunctive Treatment in Participants With Schizophr
Phase 1 · Western Michigan University · Janssen Research & Development, LLC · NCT07615426 A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Focal Segmental Glomerulosc
Phase 3 · Paragon Health Nephrology Center - Kalamazoo · Boehringer Ingelheim · NCT07220083 Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Phase 2/Phase 3 · Bronson Methodist Hospital · NRG Oncology · NCT05174169 ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathol
Phase 3 · Bronson Methodist Hospital · Alliance for Clinical Trials in Oncology · NCT06876714 Quality of End-of-Life Care for Children With Cancer
Phase N/A · Bronson Methodist Hospital · Children's Oncology Group · NCT07412002 Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SL
Phase 3 · Bronson Methodist Hospital · National Cancer Institute (NCI) · NCT04269902 Transcutaneous Electrical Stimulation and Controlled Heat in People With and Without Diabetes
NA · Western Michigan University · Western Michigan University · NCT07063524 A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed A
Phase 3 · Bronson Methodist Hospital · Children's Oncology Group · NCT04293562 Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carci
Phase 3 · Bronson Methodist Hospital · National Cancer Institute (NCI) · NCT05256225 An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerabilit
Phase 3 · Western Michigan University · Novartis Pharmaceuticals · NCT07517263 Testing Drug Treatments After CAR T-cell Therapy in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma
Phase 2 · Bronson Methodist Hospital · SWOG Cancer Research Network · NCT05633615 Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-S
Phase 3 · Bronson Methodist Hospital · National Cancer Institute (NCI) · NCT06498635 Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With G
Phase 2/Phase 3 · West Michigan Cancer Center · ECOG-ACRIN Cancer Research Group · NCT07001748 Project: Every Child for Younger Patients With Cancer
Phase N/A · Bronson Methodist Hospital · Children's Oncology Group · NCT02402244 Optimizing Reperfusion to Improve Outcomes and Neurologic Function
Phase 2/Phase 3 · Corxel Investigational Site · Corxel Pharmaceuticals · NCT06990867 Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial
Phase 3 · Bronson Methodist Hospital · ECOG-ACRIN Cancer Research Group · NCT04566328 Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma
Phase 3 · Bronson Methodist Hospital · Children's Oncology Group · NCT05235165 De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Eq
Phase 3 · Bronson Methodist Hospital · NRG Oncology · NCT04852887 Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With
Phase 3 · Bronson Methodist Hospital · National Cancer Institute (NCI) · NCT07198074 Testing a Standardized Approach to Surgery and Chemotherapy for Type I Pleuropulmonary Blastoma or the Addition of an An
Phase 3 · Bronson Methodist Hospital · Children's Oncology Group · NCT06647953 Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide,
Phase 3 · Bronson Methodist Hospital · National Cancer Institute (NCI) · NCT06058377 A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V60
Phase 2 · Bronson Methodist Hospital · SWOG Cancer Research Network · NCT04511013 Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps
NA · Bronson Methodist Hospital · NRG Oncology · NCT05080673 Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers
Phase N/A · Bronson Methodist Hospital · ECOG-ACRIN Cancer Research Group · NCT04239573 Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Remo
Phase 2/Phase 3 · Bronson Methodist Hospital · National Cancer Institute (NCI) · NCT05987241 Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The Co
Phase 2 · Bronson Methodist Hospital · National Cancer Institute (NCI) · NCT05564377

Look up another city

Look up another condition